Keywords: fda, panel, rejects, daunoxome, nda, advisory, committee

FDA PANEL REJECTS DAUNOXOME NDA

Article | 28 June 1993

Print This

An advisory committee to the US Food and Drug Administration has rejected Phase II data submitted by Vestar in support ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in